Detalles de la búsqueda
1.
Phase 3 Trial of Concizumab in Hemophilia with Inhibitors.
N Engl J Med;
389(9): 783-794, 2023 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37646676
2.
Haemophilia care in Asia: Learning from clinical practice in some Asian countries.
Haemophilia;
30(3): 609-616, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38523289
3.
Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais.
Thromb J;
21(1): 92, 2023 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37674185
4.
Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results.
Blood;
134(22): 1973-1982, 2019 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31444162
5.
Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis.
Thromb J;
18(1): 34, 2020 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33292258
6.
Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE.
J Thromb Thrombolysis;
50(2): 267-277, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32583306
7.
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF.
Am Heart J;
213: 35-46, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31128503
8.
Concizumab restores thrombin generation potential in patients with haemophilia: Pharmacokinetic/pharmacodynamic modelling results of concizumab phase 1/1b data.
Haemophilia;
25(1): 60-66, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30408848
9.
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry.
Eur Heart J;
39(6): 464-473, 2018 02 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29281086
10.
Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial.
Blood;
124(26): 3880-6, 2014 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-25261199
11.
Cancer-associated thrombosis in Asia.
Thromb J;
14(Suppl 1): 26, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27766052
12.
Correction to: Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis.
Thromb J;
18(1): 39, 2020 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-33372614
13.
Thrombosis: a major contributor to global disease burden.
Semin Thromb Hemost;
40(7): 724-35, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25302681
14.
Site-directed mutagenesis of tissue factor pathway inhibitor-binding exosite D60A on factor VII results in a new factor VII variant with lower coagulant activity.
Res Pract Thromb Haemost;
8(1): 102309, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38318153
15.
Unmet needs and barriers in venous thromboembolism education and awareness among people living with cancer: a global survey.
J Thromb Haemost;
2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38582384
16.
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls.
Eur J Epidemiol;
28(8): 621-47, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23900608
17.
Practices and challenges for hemophilia management under resource constraints in Thailand.
Orphanet J Rare Dis;
18(1): 110, 2023 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37161533
18.
Rhythm versus rate control in patients with newly diagnosed atrial fibrillation - Observations from the GARFIELD-AF registry.
Int J Cardiol Heart Vasc;
49: 101302, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38020059
19.
Country and health expenditure are major predictors of withholding anticoagulation in atrial fibrillation patients at high risk of stroke.
Open Heart;
10(2)2023 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38097360
20.
Eltrombopag in patients with chronic immune thrombocytopenia in Asia-Pacific, the Middle East, and Turkey: final analysis of CITE.
Blood Adv;
7(17): 4773-4781, 2023 09 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36103340